SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001737287-24-000065
Filing Date
2024-10-23
Accepted
2024-10-23 16:21:32
Documents
3
Period of Report
2024-10-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1729714884.html 4  
1 FORM 4 wk-form4_1729714884.xml 4 4440
2 EX-24 gparker-allogenexsection.htm EX-24 3803
3 EX-24 gparker-allogenexsection001.jpg GRAPHIC 217808
  Complete submission text file 0001737287-24-000065.txt   309761
Mailing Address 15 RIORDAN PLACE MENLO PARK CA 94025
Business Address
Parker Geoffrey M. (Reporting) CIK: 0001491874 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38693 | Film No.: 241389479

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)